Real-world efficacy data in patients with type 2 diabetes on Semaglutide

被引：0
作者：
Zitterl, Andreas [1 ,2 ]
Peric, Slobodan [1 ,2 ]
Pichler, Maximilian [1 ]
Prager, Margarete [2 ]
Prager, Rudolf [1 ,2 ]
Stulnig, Thomas [1 ,2 ]
机构：
[1] Clin Hietzing, Dept Med 3, Vienna, Austria
[2] Karl Landsteiner Inst Metab Dis & Nephrol, Vienna, Austria
来源：
WIENER KLINISCHE WOCHENSCHRIFT | 2022年 / 134卷 / SUPPL 4期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
62
引用
收藏
页码：265 / 265
页数：1
相关论文
共 50 条
  • [21] Semaglutide use in people with obesity and type 2 diabetes from real-world utilization data: An analysis of the All of US Program
    Mayer, Craig S.
    Fontelo, Paul
    DIABETES OBESITY & METABOLISM, 2024, 26 (11) : 4989 - 4995
  • [22] Once-Weekly Semaglutide Use in Type 2 Diabetes: Real-World Data from the SURE Netherlands Observational Study
    Wolffenbuttel, Bruce H. R.
    Brugts, Michel P.
    Catarig, Andrei-Mircea
    Clark, Alice
    Kok, Maarten
    Lieverse, Aloysius G.
    van Soest, Jaap
    ADVANCES IN THERAPY, 2023, 40 (03) : 920 - 933
  • [23] Once-Weekly Semaglutide Use in Type 2 Diabetes: Real-World Data from the SURE Netherlands Observational Study
    Bruce H. R. Wolffenbuttel
    Michel P. Brugts
    Andrei-Mircea Catarig
    Alice Clark
    Maarten Kok
    Aloysius G. Lieverse
    Jaap van Soest
    Advances in Therapy, 2023, 40 : 920 - 933
  • [24] Semaglutide once weekly in people with type 2 diabetes: Real-world analysis of the CanadianLMCdiabetes registry (SPAREstudy)
    Brown, Ruth E.
    Bech, Peter G.
    Aronson, Ronnie
    DIABETES OBESITY & METABOLISM, 2020, 22 (11) : 2013 - 2020
  • [25] PIONEER REAL Italy: Real-World Usage of Once-Daily Oral Semaglutide in Adults with Type 2 Diabetes
    Manti, Roberta
    De Cosmo, Salvatore
    Desenzani, Paolo
    Ferrara, Lidia
    Girelli, Angela
    Memoli, Giuseppe
    Bisio, Alessandro
    Braae, Uffe Christian
    Deinega, Alisa
    Berra, Cesare
    PIONEER REAL Italy Investigators, Massimiliano
    DIABETES THERAPY, 2025, : 1019 - 1032
  • [26] Real-world experience of adjunct weekly semaglutide in Type 1 diabetes. Is it worth it?
    Cohen, Neale
    Yeung, Asher
    Jenkins, Alicia
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2025, 219
  • [27] Real-World Use of Once-Weekly Semaglutide in Thai Patients With Type 2 Diabetes Mellitus in a Private Hospital Setting
    Thewjitcharoen, Yotsapon
    Yenseung, Nalin
    Butadej, Siriwan
    Nakasatien, Soontaree
    Chotwanvirat, Phawinpon
    Chatchomchuan, Waralee
    Wanothayaroj, Ekgaluck
    Krittiyawong, Sirinate
    Himathongkam, Thep
    JOURNAL OF THE ASEAN FEDERATION OF ENDOCRINE SOCIETIES, 2023, 38 (01): : 21 - 28
  • [28] Ramadan fasting and glycemic control in patients with type 2 diabetes: A real-world data analysis
    Salih, A. Swan-Abu
    Chodick, G.
    Klein, P.
    Eilat-Adar, S.
    PRIMARY CARE DIABETES, 2025, 19 (02) : 184 - 189
  • [29] Clinical Efficacy and Parameters Affecting the Response to Dulaglutide Treatment in Patients with Type 2 Diabetes: A Retrospective, Real-World Data Study
    Yoo, Jee Hee
    Cho, Yun Kyung
    Lee, Jiwoo
    Kim, Hwi Seung
    Kang, Yu Mi
    Jung, Chang Hee
    Park, Joong-Yeol
    Lee, Woo Je
    DIABETES THERAPY, 2019, 10 (04) : 1453 - 1463
  • [30] Clinical Efficacy and Parameters Affecting the Response to Dulaglutide Treatment in Patients with Type 2 Diabetes: A Retrospective, Real-World Data Study
    Jee Hee Yoo
    Yun Kyung Cho
    Jiwoo Lee
    Hwi Seung Kim
    Yu Mi Kang
    Chang Hee Jung
    Joong-Yeol Park
    Woo Je Lee
    Diabetes Therapy, 2019, 10 : 1453 - 1463
12345